基于《企业绩效评价标准值》的医药全行业绩效评价及预测  

Performance Analysis and Prediction of the Whole Medical Industry Based on "Standard Values of Performance"

作　　者：朱文涛[1,2] 段利忠[1] 石元元[1] 张金鹏[1] 乔延江[2] 

机构地区：[1]北京中医药大学管理学院,北京100029 [2]北京中医药大学中药学院,北京100102

出　　处：《经济与管理》2015年第4期46-50,共5页Economy and Management

摘　　要：科学合理的绩效评价是现代企业发展的基础,对行业的发展能起到促进和引导作用。通过计算医药工业全行业、化药制造业、中药材及中成药制造业三个领域全行业综合绩效发现,2008—2014年,中药材及中成药制造业最优,医药工业全行业次之,化药制造业最低。同时通过灰色关联GM(1,1)模型对医药行业绩效进行预测可知,未来五年医药全行业绩效均呈上升趋势。Scientific performance evaluation is the basis of enterprise development, which plays a promoting and guiding role in the development of an industry. In order to analyze and predict the performance situation of pharmaceutical industry, chemicals manufacturing industry and manufacturing industry of Chinese medicinal materials and Chinese patent medicine, the comprehensive performance was calculated by entropy value method and weighting method. In the view of comprehensive performance, from 2008 to 2014, the order of three industries from most to least is pharmaceutical industry, manufacturing industry of chinese medicinal materials and chinese patent medicine and chemicals manufacturing industry. Prediction was made by grey correlation method GM（1,1）, there is a stable rising trend in the next 5 years.

关 键 词：绩效 医药全行业 熵权法 灰色关联法 评价 预测 

分 类 号：F224[经济管理—国民经济] F426